DI BELLA METHOD
>
DOCUMENTATION INDEX > Patient Area - Documents
Cushing syndrome as a presenting symptom of renal tumors in children.
(05/04/2011)
Detail
Optimizing acromegaly treatment.
(05/04/2011)
Detail
Update in prolactinomas.
(05/04/2011)
Detail
Eight-year follow-up of a child with a GH/prolactin-secreting adenoma: efficacy of pegvisomant therapy.
(05/04/2011)
Detail
The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells.
(05/04/2011)
Detail
Immunohistochemical expression of pituitary tumor transforming gene (PTTG) in
(05/04/2011)
Detail
Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation
(05/04/2011)
Detail
Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation.
(05/04/2011)
Detail
An attempt at conservative treatment in selected cases of type I endometrial carcinoma (stage I a/G1) in young women.
(05/04/2011)
Detail
Bromocriptine induces parapoptosis as the main type of cell death responsible for experimental pituitary tumor shrinkage.
(05/04/2011)
Detail
Polycystic ovary syndrome and prolactinoma association.
(05/04/2011)
Detail
Pre-operative dopamine agonist therapy improves post-operative tumor control
(05/04/2011)
Detail
Research resource: estrogen-driven prolactin-mediated gene-expression networks in
(01/04/2011)
Detail